Prof Pablo Avanzas, MD, PhD, MSc, FESC is an expert in Cardiology at Central University Hospital of Asturias (Spain). As of November 2026, ScienceLeadR ranks Pablo Avanzas in the top 1% of experts worldwide for Myocardial Ischemia. Pablo Avanzas has authored 585 publications, the most recent in 2026, and is an investigator in 15 clinical trials, 2 of them ongoing. SLR score: 1,650 (community average: 125). How the SLR is computed.

LeadR Profile

Prof Pablo Avanzas, MD, PhD, MSc, FESC Central University Hospital of Asturias Spain
1 650 ScienceLeadR Reputation 1650
Network Map

Cardiology

Subspecialties: Public Health - Biostatistics - Surgery

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2004 - 2026
Source: PubMed

Central University Hospital of Asturias - Interventional Cardiologist

2004 - 2026

Instituto de Investigación Sanitaria del Principado de Asturias - Investigador

2017 - 2026

University of Oviedo - Profesor Titular de Cardiología

2018 - 2026

University of Buenos Aires

2019 - 2026

Centro de Investigación en Red en Enfermedades Cardiovasculares

2023 - 2026

Centro de Investigación Biomédica en Red

2023 - 2026

Instituto de Salud Carlos III

2023 - 2026

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 585

Citations

Citations: 11 864 1st author: 63 Last author: 98 Unique author: 4


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Influence of diabetes mellitus on dapagliflozin response after transcatheter aortic valve replacement (TAVR): insights from the DAPA-TAVI trial.
PMID 43004293 — diabetes mellitus, mortality, aortic valve, transcatheter aortic valve replacement, therapeutics, diabetes complications
Cardiovasc Diabetol20260
Mechanical Complications After Acute Myocardial Infarction: Contemporary Management, Treatment Selection, and Outcomes in a 10-Year Regional Referral Network.
PMID 42941488 — mortality, myocardial infarction, income, aged, sex, aneurysm, false, therapeutics, rupture, ventricular septal rupture, mechanical circulatory support
J Clin Med20260
Dapagliflozin After Transcatheter Aortic Valve Implantation According to Frailty in DapaTAVI Trial.
PMID 42885795 — aortic valve stenosis, heart diseases, heart failure, aortic valve, transcatheter aortic valve replacement, frailty
J Am Heart Assoc20260
Optical coherence tomography for the diagnosis and management of stent thrombosis.
PMID 42745727 — stents, tomography, tomography, optical coherence, diagnosis, thrombosis, acute disease
REC Interv Cardiol20250
Update on Perioperative Prevention of Cardiac Surgery-Associated Acute Kidney Injury.
PMID 42739538 — acetylcysteine, kidney, cardiopulmonary bypass, reperfusion injury, renal replacement therapy, acute kidney injury
J Clin Med20260

Clinical Studies 15

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

N/A 9
Phase 3 5
Phase 4 1

By status:

Completed 8
Active not recruiting 2
Recruiting 2
Terminated 2
Unknown 1

By type:

Interventional 12
Observational 3

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 0
multicentric5to9 1
multicentricup10 12

Main Topics

Cohort/Consortium Investigators 1

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Surgical vs Transcatheter Aortic Valve Replacement in YOUNG Patients
NCT06861361 — constriction, pathologic, aortic valve stenosis, bioprosthesis, heart, aged, aortic valve, transcatheter aortic valve replacement, surgical aortic valve replacement
N/ARecruiting2025
Early Transcatheter Mitral Valve Repair After Myocardial Infarction
NCT06282042 — mitral valve, myocardial infarction, therapeutics, mitral valve insufficiency
N/ARecruiting2024

LeadR Networks

Main global connection map